Comparing Two Flu Vaccines for People With HIV
Part of Infections, Lungs & breathing clinical trials.
This study compares two different flu vaccines to see which one works better for people living with HIV. One vaccine uses a special ingredient called MF59 to boost immune response, while the other is a high-dose version. The goal is to understand which approach helps your body fight off the flu more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have HIV (are living with HIV)
- You have not had a severe allergic reaction or other serious side effect from any flu vaccine in the past
- You do not have a blood clotting disorder that would make vaccination unsafe
- You have not already received a 2026-2027 flu vaccine this season
- You have not had the flu in the past month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of flu vaccines (one with an immune booster called an adjuvant, and one without) in people with HIV who are over 50. Researchers want to see which vaccine triggers a stronger immune response to better protect you from the flu.
This study compares two types of flu shots for people 65 and older to see which works better. If you are a Kaiser Permanente member and get your flu shot at a Kaiser facility, this trial looks at your health records to see how well the vaccine protected you.
This study compares a high-dose flu vaccine to the standard dose in lung transplant recipients. It aims to see if a higher dose gives better protection against the flu.
This trial tests whether a higher dose of flu vaccine works better than the standard dose for people who have had a lung transplant. It may help improve protection against seasonal flu while monitoring safety.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial tests how well the flu vaccine works in people with blood cancers like lymphoma, leukemia, or multiple myeloma. It aims to find the best vaccination strategy to protect you during treatment.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.